Lung cancer is the most common fatal malignancy in both men and women.
Lung cancer is found in all stages df chronic obstructive pulmonary d
isease (COPD), including mild to moderate degrees of airflow obstructi
on. Thus, simple spirometric measurements of airflow, that is, forced
expiratory volume in 1 second (FEV(1)), and the ratio of the FEV(1) to
the forced vital capacity will identify patients at highest risk of l
ung cancer, particularly if they are smokers. Lung cancer is seven tim
es more common when airflow obstruction is present than when airflow i
s normal. The spirometer not only identifies the fact of airflow obstr
uction but serves as a surrogate marker for deaths from all causes, in
cluding lung cancer, heart attack, and stroke. Early identification an
d intervention are the keys to altering the courses of both lung cance
r and COPD and reducing the risk of associated disease states.